“…9,10 The causes of limb loss in patients despite patent grafts have included extensive infection, poor pedal runoff, failure to reverse ischemia at the site of tissue loss, heel necrosis (Ͼ4 cm), and forefoot gangrene, especially in patients with diabetes and end-stage renal disease, 8 and primary amputation has been suggested in these patients. 1,5,7,8 The adoption of complex endovascular interventions has allowed limb salvage attempts in higher-risk patients who would otherwise not have been considered for revascularization, making the decision for primary amputation more complex. [11][12][13][14] Although the adoption of an aggressive endovascularfirst approach for all comers with critical limb ischemia has decreased the primary amputation rate from 15% to 4%, accompanied by a decrease in limb loss in patients in whom limb salvage was attempted, 13 we have found that most amputations occurred in patients with patent endovasculartreated segments (PETAS), which other authors have also described.…”